Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 7, 2021Scientific ReportsOpen Access

Design, synthesis, molecular docking, and in vitro α-glucosidase inhibitory activities of novel 3-amino-2,4-diarylbenzo4,5imidazo1,2-apyrimidines against yeast and rat α-glucosidase

View Full Paper
Ask AI
Bookmark
Share

Authors

FPFariba PeytamTehran University of Medical SciencesGTGhazaleh TakalloobanafshiTSToktam SaadattalabTehran University of Medical Sciences

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Peytam et al. (2021) studied this question.

synapsesocial.com/papers/6a8a920a06e1858e55de97a1https://doi.org/10.1038/s41598-021-91473-z
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Diagnosis and Classification of Diabetes Mellitus2010 · 14,027 citations
  2. 2Phosphoramidates as Steering Elements for Highly Selective Access to Complementary Imidazo[1,2-a]pyrimidine Isomers2019 · 14 citations
  3. 3Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes2008 · 359 citations
  4. 4Synthesis,in vitroinhibitory activity, kinetic study and molecular docking of novelN-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors2020 · 20 citations
  5. 5Access to Imidazo[1,2-a]pyridines via Annulation of α-Keto Vinyl Azides and 2-Aminopyridines2015 · 67 citations